RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
2.250
+0.010 (0.45%)
Apr 24, 2025, 10:56 AM EDT - Market open

RedHill Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
482913135302
Upgrade
Market Cap Growth
-72.32%-72.32%124.48%-90.53%-55.27%41.19%
Upgrade
Enterprise Value
-0124118188353
Upgrade
Last Close Price
2.246.2136.50140.302580.008080.00
Upgrade
PE Ratio
--1.20---
Upgrade
PS Ratio
0.340.994.400.211.584.70
Upgrade
PB Ratio
-0.84-1.7013.88-0.2615.2321.80
Upgrade
EV/Sales Ratio
-0.153.681.922.195.49
Upgrade
Debt / Equity Ratio
-0.08-0.080.57-2.539.896.27
Upgrade
Asset Turnover
0.390.390.070.360.480.51
Upgrade
Inventory Turnover
0.790.790.452.584.638.78
Upgrade
Quick Ratio
0.340.340.440.280.870.81
Upgrade
Current Ratio
0.540.540.810.441.090.96
Upgrade
Return on Equity (ROE)
-----859.70%-206.25%
Upgrade
Return on Assets (ROA)
-37.28%-37.28%-15.71%-15.75%-28.06%-31.30%
Upgrade
Return on Capital (ROIC)
---36.87%-31.32%-51.36%-48.37%
Upgrade
Earnings Yield
-210.68%-103.97%83.26%-560.09%-72.30%-25.20%
Upgrade
FCF Yield
-238.96%-117.93%-124.74%-229.63%-48.20%-16.21%
Upgrade
Buyback Yield / Dilution
-375.56%-375.56%-320.45%-32.46%-27.72%-22.69%
Upgrade
Updated Aug 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q